Moderna market cap 2021

Medical worker Robert Gilbertson loads a syringe with the Moderna Covid-19 vaccine. APU GOMES |…

Biotech and pharmaceutical company Moderna, a pioneer in developing coronavirus vaccines, has the potential to reach a market cap of over $ 100 billion, according to an analyst. Market Cap. US$52.3b. Last Updated. Market. How volatile is .

21.11.2020 Moderna market cap 2021

The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth. Moderna’s shares rose 3% in premarket trade Thursday as its fourth-quarter revenue, of $517 million, vastly exceeded estimates of $318.9 million. It also forecast $18.4 billion in Covid-19 vaccine In depth view into Moderna Market Cap including historical data from 2018, charts, stats and industry comps. 2021: 52.32B March 8, 2021 : 49.36B Market Capitalization is expected to dwindle to about 7.3 B. From 2010 to 2021 Moderna Market Capitalization quarterly data regression line had arithmetic mean of 5,488,712,160 and slope of 207,239,765. Moderna Gross Profit is projected to decrease significantly based on the last few years of reporting.

Mar 04, 2021 · Moderna stock opened at $131.22 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.43 and a quick ratio of 2.43. The company has a market capitalization of $52.46 billion, a PE ratio of -81.00, a price-to-earnings-growth ratio of 0.53 and a beta of 1.73.

APU GOMES | AFP | Getty Images Biotech and pharmaceutical company Moderna, a pioneer in developing coronavirus vaccines, has the potential to reach a market capitalization of over $ 100 billion, according to an analyst. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

advertising $100 billion market cap is the blue sky state of affairs for Moderna: analyst 2021-02-25 14:30:50 advertising Medical employee Robert Gilbertson masses a syringe with the Moderna Covid-19 vaccine.

Day Range. 125.60 132 "If you put a 10-times-sales multiple on that then, you can do the math, then it's a $100-billion-plus market cap company," he added. Image source: Getty Images. Moderna rose to fame on mRNA-1273 Market Cap: 52.318B: Beta (5Y Monthly) 1.47: PE Ratio (TTM) N/A: EPS (TTM)-1.96: Earnings Date: May 05, 2021 - May 10, 2021: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Moderna named Fast Company’s Most Innovative Company for 2021. 2021. About Moderna. with a $50 billion market cap, is a major player in the midstream segment, and operates a network of Mar. 6, 2021 at 2:30 p.m.

Barclays boosted their price target on Moderna from $169.00 to $178.00 in a report on Friday.

ET by Rachel Koning Beals Moderna Inc. stock falls Friday, underperforms market Mar. 5, 2021 at 4:31 p.m. ET by MarketWatch Automation Moderna has a market capitalization of $62 billion. That equates to about 5.6x its projected COVID-19 revenue of $11 billion in 2021. Next year would represent peak revenue. Nevertheless, a large market cap is not a major cause for concern, given the company’s revenue potential. there is a good chance Moderna will be profitable by the end of 2021.

Moderna market cap as of March 05, 2021 is $52.85B. Compare MRNA With Other Stocks Moderna Therapeutics is pioneering a new class of drugs, messenger RNA Therapeutics, with the vast potential to treat many diseases across a range of drug modalities and therapeutic areas. Find out all the key statistics for Moderna, Inc. (MRNA), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Get the latest Moderna Inc (MRNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Should you invest in Moderna (NasdaqGS:MRNA)? Flawless balance sheet with limited growth.

Day Range. 125.60 132 Jan 28, 2021 · Moderna has won the Covid-19 vaccine race and could bring in $11.7 billion with its candidate in 2021. But is MRNA stock overpriced? Feb 25, 2021 · Moderna’s shares rose 3% in premarket trade Thursday as its fourth-quarter revenue, of $517 million, vastly exceeded estimates of $318.9 million. It also forecast $18.4 billion in Covid-19 vaccine Oct 23, 2020 · Analysts are only guessing about the company's results in the next few months. The average analyst estimate for Moderna's 2021 revenue is just shy of $5 billion, but the low estimate is $200 Mar 09, 2021 · The firm has a market cap of $49.36 billion, a PE ratio of -76.22, a price-to-earnings-growth ratio of 0.53 and a beta of 1.73.

Earnings Date, May 05, 2021 - May 10, 2021. Forward Dividend & Yield MRNA | Complete Moderna Inc. stock news by MarketWatch. Last Updated: Mar 12, 2021 10:09 a.m. EST Real time quote Market Cap $56.21B; Shares Outstanding 400.18M; Public Float 336.71M; Beta 0.25; Rev. per Employee $618.00K ..

thajský baht až sgd
20000 bahtov v usd
v hotovosti alebo kartou prijímate reddit karmu
1 milión prevedený na inr
ako je možné získať štátom vydané identifikačné číslo online
najnovšia kryptomena, ktorá ťaží 2021
číslo jeden desetník texty

Moderna has a market capitalization of $62 billion. That equates to about 5.6x its projected COVID-19 revenue of $11 billion in 2021. Next year would represent peak revenue.

Share In depth view into Moderna Market Cap including historical data from 2018, charts, stats and industry comps. March 12, 2021, 54.84B. March 11, 2021, 56.26B. Market Cap, 56.262B.